QUALITATIVE & QUANTITATIVE ANALYSIS OF FALICAIN CONDUCTED AT ROSTOCK UNIVERSITY

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
CIA-RDP81-01030R000100300004-3
Release Decision: 
RIPPUB
Original Classification: 
S
Document Page Count: 
5
Document Creation Date: 
December 23, 2016
Document Release Date: 
August 12, 2013
Sequence Number: 
4
Case Number: 
Publication Date: 
October 30, 1953
Content Type: 
REPORT
File: 
AttachmentSize
PDF icon CIA-RDP81-01030R000100300004-3.pdf159.94 KB
Body: 
, 50X1-HUM Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81-01030R000100300004-3 t.74- CENTRAL INTELLIGENCE AGENC INFORMATION REPORT SECRET SECURITY INFORMATION COUNTRY East Germany , SUBJECT Qualititive-& Quantitative Analysis of Falicain Conducted at BOtock %University ? DATE OF INFO. PLACE ACQUIRED REPORT DATE DISTR. NO. OF PAGES REQUIREMENT REFERENCES 50X1-HUM 30 October 1953 5 ? 50X1-HUM 50X1-HUM THE SOURCE EVALUATIONS IN THIS REPORT ARE DEFINITIVE. THE APPRAISAL OP CONTENT IS TENTATIVE. (FOR KEY SEE REVERSE) 50X1-HUM srcRET STATE I #X I ARMY WX I NAVY WX I A IR WYC I FEI, AEC Note: Washington Distribution Indicated By "X", Fiold Distribution By "#".) 50X1-HUM . Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81-01030R000100300004-3 Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81-01030R000100300004-3 ?COUNTRY SUBJECT .East Germany SECRET SECURITY INFORMATION t Qualitative and Quantitative Analysis of ralioain Conducted at Roetook University PLACE ? ACOUIRED 4 '? DATE ACQUIRED DATE OF INFORMATION THIS IS UNEVALUATED INFORMATION 50X1-HUM 50X1-HUM DATE DISTR. // sePt-C? NO. OF PAGES 4 NO. OF ENCLS. 50X1-HUM (LISTED BELOW) SUPPLEMENT TO REPORT NO. 50X1-HUM 16 In. 1951, Dr. Rer. Nat. Harald BRAEUNIGER, chief assistant (Oberassistent) in the Chemistry Institute of Rostock University and director (Leiter) df?the.pharmaceutioal section of this inetitutesuggested kresearoh ptejedt, which would enable to complete the requirements for a 50X1-HUM doctorate. The project was to investigate methods for qualitative anf quantitative analysis of. Falieain gtcain is beta-pipeiifino, 4-propoxyPhenyl-ketone hYfioehlorids. and ite degradation Products. y the required research work on this project in the 50X1-HUM ' ? pharmaceutical section of the Chemistry Institute from. October 1951 . until March 1953 under Dr:.BRAEUNIGER's technical direction. ?50X1-HUM ? doctorate thesis titled "Investigations on the Qualitative and . Quantitative Analysis of_Falicain and its Degradation Productel, includef Our findinip. A synopsis of this repott is attached ages 3 through a inclusive . c. ' ? 2. Patioain was synthesizeeby Dr. Phil. Elmer PROFFT.of Magdebuigi He ? -? hdediecovered that the propoxyhomolog of one-alkoxy, two..4minoi four- ? -inCtibbenzeneceieeteningagentaIhad anesthetic properties. While pursuing this investigation he prepared Falicain, which was found to ha*e.Otrong surface anesthetic action. ? 3. This new produot has been subjected to pharmacological testing at the ? ? pharmacoloral Institutes! in Halle and Rostock. I clinical tr ale are still being conducted.' Outstanding contributors to the subject include Dr. HANNIG (Halls), Dr. PIETSCH (Eye ? .LeiPsig University)1Dr. GOTZEN (Eye Clinic', Halle University), ; ? Bx SCHULTE (Magdeburg) Mr. ORTEL (Dental-Clinic, Halle), and ' SECRET Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81:01030R000100300004-3 50X1-HUM eissi declassified in Part - Sanitized Copy Approved for Release 2013/08/12: CIA-RDP81-01030R600100300004-3 4. SECRET -2- 50X1-HUM Prof. %Dr. Peter HOLTZ (formerly of the Pharmacological Institute, Rbetook. and presently at ? Prankfurt/M University) c Palioain was available on ,the .market in the Soviet Zone of Germany under the names Dentofalioain, Ophthafaliciain, Falipid and Rektafalioain. SECRET 50X1-HUM Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81-01030R000100300004-3 ? - , Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81-01030R000100300004-3 . . ? ? SECRET -3- "Investigations ohthe Qualitative and Quantitative Analysis of Palioain and its Degradation Products" 1. This thesis represented a report of work which under the teOhnical guidance of Dr. H. BRAEUNIOER in the pharmaceutical section of the Chemistry Institute of Rostock ' University from October 1951 Until March 1953. , ?? 2. In this work methods for the qualitative and ' quantitative analysis of Palioain and its degradation produnts. the chemical identity of Falicain by Preiiiing betas 50X1-HUM pper no -s ?yl-p-propoxyphenylketone hydroohloridh(which is the structure of Falicain as claimed by its original synthesizer Dr'. Eller SWIFT Of:Nagdeburg). and comparing this product with Falioein. ao Preparation of beta-piperidino-thyl-p-propoxyphenyl- ketone hidrochloride (PPP) is as follows' . kmixtuih 0"parafOrma1dehyde'and piperidine hydro- chloride in absolute alcohol is combined, according to the Mannich condensation, with p-propoxyaceto- Hphenone. Tbehrystailine product Obtained. has pleftile4bA'iif163 C which, fl is not ohangedibrreoryetallization rom a cohol-acetone.. . - ? ? . Prepared derivativehof PP% and Falicain, viz:, oxime, two, four-4ipitioihenylhydrazone, reineekite;:hid cobalt tetrAnitrosodiamine compleiohowed identical' properties. after synthesis under the same conditions.. 4. Palicain ihdecoMppied by-heating in aqueous solution;:but- ihadeqUate-amountsf:ordearadation pioducte can be Jar:slated' for identification... subjected Falicain 'to vaiiiimm. 50X1-HUM distillation and obtained'the, following compounds'. a. Piperidine--demonstrated by boiling point deteriina- tion, by_preparation of the reineckate. b. p-Propoxyphenyl-vinyl ketend-demonstrated by preparation of the.hidrazone, two, four- I? -dinitroPhenylhydrazone-and.broMination produnt. 3. 4. 50X1-HUM 50X1-HUM 50X1-HUM 50X1-HUM SEC RET C.? 0 Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP-81-01030R000100300004-3 Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81-01030R000100300004-3 51, SECRET The absorption curve of Falicain in ilmeasured with the aid of a Zeiss alio-generator is a Zeiss instrument of arcs per second is maintained at Motor. the speetrum of A 'tungsten arc quartz apectiegraph Q 24. The. of type PP 20 in Which the number 100 by means of a aynchronic .4024eilthe(ifOlTheing quantitalitiMA0** analysis to PaliUalmi ? a.; Argentometric, consisting of a simple Vollhard titratiOn' of the chloride ion in the hydrochloride salt. . b. Titration of Falicain-reineckate,' consieting of .a Vollhard potentiometric.titration of the rhodanide of .the complex released upon decomposition of the reineckate salt with'. potassium sodium tartrate. . , Propoxyl determination of Falicain, cOneisting.of.a.decom_. position of-the propoxyl compound by the Zeieel'method.and titration of the iodine released from the propyriodide with sodium' thiosulfate. C? 'with only moderate succesi, to apply iontophoresis to .the separation of Falicain and degradation products. No practical application of this process was developed, other than to show that thestalioain solution had decomposed. is 8. Colorimetric methods which employei 'for the quanti- tetive.analysis of Falicain consist of the following (Lange- 1 Colorimeter, Type IV was used): ? A. Reineckate in acetone solution. b; Cobalt complex in alcohol solution (Erdmanh'i salt). 0. Ferronitrososulfate produoed by decomposing the. Falicain- cobalt complex and adding ferrous ion to the released' 'Oto?Poloo?osool, nitrite. :m-Dinitrobenzene reaction. ? 9. polarographicjanalysesviith dome success for .quantitative assay Of Falicain. 'The'coMpounds-studied ,were' the following:. Ylos? Faiicain )1\ 50X1-H UM 50X1-H UM ? 50X1 -HUM 50X1-H UM 50X1 -HUM b. Falicain-reineckate and hyrolysis-products from this salt. (These were unsuitable for this assay.) ? CO Falicain decomposed by subjection to heating in aqueous solution. This assay showed that Falicain can be polaro- graphed quantitatively in the presence of its breakdown products. 4. Falicain hydrolyzed in the above fashion under conditione of complete absence of oxygen. This demonstrated that the hydrolysis of Falicain is independent of oxygen Presence. e. Falicain hydrolyzed in the above fashion under conditioni of varying hydrogen ion concentration, elevated temperature and elevated pressure. Thie demonstrated that pH changes:affected the rate of decomposition, i.e., the greater the acidity, the less decomposition occurred. The greater the amount of heat applied, the greater is the decomposition. Increase of pressure causes greater breakdown. SECRET Declassified in Part - Sanitized Copy Approved for Release 2013/08/12 : CIA-RDP81-01030R000100300004-3